The in vivo genotoxic effects of the antitumor
antibiotic, (+)-
CC-1065, and its unnatural enantiomer, (-)-CC-1065, were investigated in two mouse models. These two compounds alkylate AT-rich regions of
double stranded DNA with distinct sequence selectivities. (+)-
CC-1065 dose-dependently increased the
chromosomal aberration frequency in bone marrow cells of CD-1 mice from 1.2 +/- 0.8% in vehicle control animals to 5.0 +/- 1.2%, 11.4 +/- 3.9%, and 20.6 +/- 2.3% 24 hours following single intravenous doses of 2, 4, and 8 micrograms/kg, respectively. (-)-CC-1065 was significantly less potent with a maximal response at 8 micrograms/kg approximately one-third of that observed for (+)-
CC-1065. (+)-
CC-1065 induced a significant (P < or = 0.05), three-fold increase in the number of lung
tumors/mouse in strain A/J mice from 0.27 +/- 0.15 for vehicle control animals to 0.83 +/- 0.15 24 weeks following a single intravenous dose of 8 micrograms/kg. This effect was paralleled by corresponding threefold increases in the percentage of mice with
tumors and the percentage of mice with multiple
tumors, compared to vehicle controls. (-)-CC-1065 at 8 micrograms/kg induced 0.67 +/- 0.15
tumors/mouse and resulted in slightly smaller increases in the
tumor incidence and multiple
tumor incidence, compared to (+)-
CC-1065. The above results demonstrate that single intravenous doses of (+)-
CC-1065 and (-)-CC-1065 which cause chromosomal damage in CD-1 mice also induce an increased incidence of lung
tumors in A/J mice.(ABSTRACT TRUNCATED AT 250 WORDS)